The Jonah Finn Foundation

Harnessing the power of collaboration and AI, M-PACT is a deep learning model using DNA methylation, that facilitates next-generation classification of pediatric brain tumors by CSF biopsy.  nature.com/articles/s4301…

Servier plans to acquire Day One Biopharmaceuticals is a reminder that investment in pediatric brain cancer research matters and delivers breakthroughs 💛 oncodaily.com/techology/serv…

In ETMR, loss or alteration mutations of DICER1 disrupt microRNA processing, contributing to abnormal gene regulation.  This study shows DICER1 contains 2 binding pockets that coordinate accurate production of sm reg RNAs during microRNA biogenesis. #ETMR nature.com/articles/s4158…

Single-nucleus profiling of ATRTs uncovers subtype-specific developmental pathway, and shows tumor cells can be pushed toward differentiated, non-proliferative states, supporting maturation-based, tailored therapies. academic.oup.com/neuro-oncology…

ETMR tumor in 3 year old treated with double autologous transplant at Andhra's HBCH&RC #ETMR newindianexpress.com/states/andhra-…

Meet Marky the Fighter nbcconnecticut.com/video/news/loc…

The JFF is proud to announce that our VP, Suzy Amor, is on Capitol Hill today alongside her advocacy group from DFCI — sharing Jonah’s story with members of Congress, petitioning for increased funding for pediatric cancer research. We fight for every child and family impacted!

Rhabdoid tumours are rare, aggressive childhood cancers with <30% survival in high-risk cases. New research prioritizes targeted strategies based on shared SMARCB1/SMARCA4 loss: DCAF5 and EZH2 degraders, MDM2-based combinations, FGFR/PDGFR inhibitors nature.com/articles/s4141…

The JFF VP, Suzy Amor, will run the 2026 Boston Marathon in honor of Jonah and all ETMR warriors🖤🏃‍♀️ Suzy is dedicating this race to @NHLBruins Foundation & The Jonah Finn Foundation for children, families & cancer research. Please consider donating givengain.com/project/suzy-r…

Pediatric Cancer Bill Torpedoed by Elon, Rand, and Bernie Finally Passes open.substack.com/pub/thebulwark…

Antonio Amor's obituary rosehillfuneralhomect.com/obituaries/Ant…

The American Association for Cancer Research (AACR) released the inaugural AACR Pediatric Cancer Progress Report on December 4 on Capitol Hill in Washington, D.C. Watch this briefing video: vimeo.com/1143866686

Pratiti (Mimi) Bandopadhayay, Peter B. Dirks, Adam D. Durbin, Jaume Mora, and Nina Weichert-Leahey discussed "Pediatric Cancer Development" in a plenary session at the AACR Conference on Pediatric Cancer Research. #AACRpediatric25 @BrainSurgn1989 @ADurbinLab

Mechanisms Underlying Childhood Cancer: Charles Roberts, Mariella G. Filbin, Liling Wan, Susu Zhang, and Alexander Zhang addressed this topic in a plenary session at the AACR Conference on Pediatric Cancer Research. #AACRpediatric25 @TheRobertsLab1 @FilbinMariella @LilingWanLab

Deadline Extended!!! for The 2026 ASPNR-Guerbet Research Grant. This $25,000 award is designated to advance research in pediatric central nervous system imaging. ✨ Deadline: October 3, 2025 Researchers are encouraged to apply via the following link: surveymonkey.com/r/ZQ5DDV8 #ASPNR26 #PediatricNeuroradiology #ResearchGrant #AcademicFunding #NeuroimagingResearch

Even the rarest tumors are worthy of researching as seen in this publication: bit.ly/4gG0mYA. A tumor called an embryonal tumor with multilayered rosettes (ETMR) is a rare tumor that may be found in infants in their brain and spinal cord. #PediatricCancerAwarenessMonth

Brain tumors are the leading cause of pediatric cancer-related death, and each year close to 5,000 children are diagnosed with them. In August, the Trump administration announced it would stop supporting a federally funded network dedicated to researching these deadly cancers. Misha Mehta, president of the Neev Kolte & Brave Ronil Foundation, and Dr. Paul Graham Fisher, co-investigator in the Pediatric Brain Tumor Consortium, joined @alirogin to discuss the implications of the loss of funding.

The AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer—From Biology to Breakthrough Therapies, Sept. 25–28 at The Westin Copley Place, Boston. Experts will share the latest research and therapeutic advances in pediatric brain cancer. #AACR